Quick Takeaways
- Deep Track Capital, LP filed SCHEDULE 13G for Immunovant Inc. Common Stock, $0.0001 par value per share (IMVT).
- Disclosed ownership: 5.6%.
- Date of event: 19 Mar 2025.
Deep Track Capital, LP - 19 Mar 2025 SCHEDULE 13G Report for Immunovant Inc. Common Stock, $0.0001 par value per share (IMVT)
- Filing Manager
- Deep Track Capital, LP
- Reporting Manager
- Deep Track Capital, LP
- Symbol
- IMVT
- Shares outstanding
- 169,946,333 shares
- Disclosed Ownership
- 9,500,000 shares
- Ownership
- 5.6%
- Form type
- SCHEDULE 13G
- Filing time
- 26 Mar 2025, 16:09:37 UTC
- Date of event
- 19 Mar 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Deep Track Capital, LP disclosed 5.6% ownership in Immunovant Inc. Common Stock, $0.0001 par value per share (IMVT) on 19 Mar 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 26 Mar 2025, 16:09.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Deep Track Capital, LP | 5.6% | 9,500,000 | 0 | 9,500,000 | /s/ David Kroin | David Kroin, Managing Member of the General Partner of the Investment Adviser | |
| Deep Track Biotechnology Master Fund, Ltd. | 5.6% | 9,500,000 | 0 | 9,500,000 | /s/ David Kroin | David Kroin, Director | |
| David Kroin | 5.6% | 9,500,000 | 0 | 9,500,000 | /s/ David Kroin | David Kroin |